14
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Laser speckle flowgraphy findings in focal scleral nodule

      letter

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Dear Editor. Focal scleral nodule (FSN), renamed by Fung et al. in 2020 [1], is characterized by the partial elevation of the sclera and a solitary yellowish-white spot with clear boundaries. In the FSN lesion, the choroidal circulation may be locally impaired given previously reported hypofluorescence on indocyanine green angiography (ICGA) and nonperfusion of choriocapillaris on optical coherence tomography angiography [1]. To date, surveying macular choroidal blood flow using laser speckle flowgraphy (LSFG) has played an important role in elucidating the pathophysiology of various fundus diseases [2–8]; however, the LSFG findings of FSN has not been reported so far. Here, we report the LSFG findings in 2 FSN cases. We would like to describe 2 cases. Our first case was a 56-year-old woman who was found to have an abnormality in her right fundus. Her medical and family history was unremarkable. The patient’s best-corrected visual acuity (BCVA) was 20/20 OD. Funduscopic examination revealed an orange lesion of less than two-disc diameter on the inferonasal site of the macula (Fig. 1a). Fluorescein angiography (FA) showed scattered hypofluorescence and surrounding hyperfluorescence (Fig. 1c) in the early phase followed by granular enhancement (Fig. 1d). ICGA showed hypofluorescence in the early phase (Fig. 1e) and surrounding slight hyperfluorescence in the late phase (Fig. 1f). On enhanced depth imaging optical coherence tomography (EDI-OCT), the sclera was elevated with the overlying choroid thinned to 20 μm (Fig. 1g), whereas the central choroidal thickness was 144 μm. B-mode echography showed no acoustic shadow (Fig. 1h). Contrast-enhanced MRI of the head and orbit (Fig. 1i), gallium scintigraphy, and blood tests showed no abnormal systemic or ocular findings. The patient was diagnosed with FSN and followed up without treatment. Five years later, the yellowish-white lesion and surrounding orange halo became funduscopically more evident than at the first visit (Fig. 1b). Fig. 1 Images of the right eye in a patient (Case 1) with focal scleral nodule (FSN). a The fundus photograph at the initial visit showing an orange lesion with well-defined choroidal vessels less than the two-disc diameter at the inferonasal site of the macula. b The FSN lesion was yellowish-white, and the surrounding orange halo became evident 5 years later. c Early-phase fluorescein angiography (FA) shows scattered hypofluorescence and surrounding hyperfluorescence. d The hyperfluorescence turned to granular enhancement in the late phase of FA. e Early-phase indocyanine green angiography showing hypofluorescence at the lesion. f The hypofluorescence persisted with a new surrounding hyperfluorescence in the late phase. g Enhanced depth imaging optical coherence tomography showing the elevation of the sclera, with the overlying choroid thinned to 20 μm. h B-mode echography showing an elevated lesion (white arrow), but without acoustic shadow suggestive of calcification. i Contrast-enhanced MRI of the orbit shows no abnormal findings, including orbital tumors. j The laser speckle flowgraphy color map 1 year after the initial visit showing localized cooler color (white arrowheads) corresponding to the FSN lesion, indicating blood flow impairment The LSFG color map of mean blur rate (MBR) showed localized cooler color at the lesion (white arrowheads, MBR = 4.6) than at the macula (black arrowheads, MBR = 7.7), indicating blood flow was disrupted in the FSN site (Fig. 1j). Our second case was a 56-year-old woman who was referred to our clinic because of a yellowish-white lesion in her left macula. Past medical and family history was unremarkable. BCVA was 20/16 OS. The fundus and other findings were similar to those in Case 1 (Fig. 2a–i), but the elevation was closer to the macula and steeper. Late-phase FA showed hyperfluorescence across the fovea, indicating retinal pigment epithelial damage (Fig. 2d). Fig. 2 Images of the left eye in a patient (Case 2) with focal scleral nodule (FSN). a The fundus photograph at the initial visit showing a whitish-yellow lesion of about one-disc diameter with an orange boundary neighboring the fovea. b The lesion and surrounding orange halo became more evident in the fundus photograph 5 years later. c Early-phase fluorescein angiography (FA) showing window defects corresponding to retinal pigment epithelium atrophy around the whitish-yellow lesion. d The hyperfluorescence was enhanced in the late phase of FA. e Early-phase indocyanine green angiography showing low fluorescence at the lesion. f The hypofluorescence lesion persisted in the late phase. g Enhanced depth imaging optical coherence tomography showing the elevation of the sclera (white arrow), with the choroid compressed compared to the other parts of the choroid. h B-mode echography showing an elevated lesion (white arrow) with no acoustic shadow. i Contrast CT of the orbit showing no abnormal findings. j The laser speckle flowgraphy color map 3 months after the initial visit showing apparent solitary cooler color (white arrowheads) corresponding to the lesion On LSFG, the lesion showed a cooler color (Fig. 2j white arrowheads, MBR = 3.3) than the macula (black arrowheads, MBR = 10.2), indicating blood flow reduction in the FSN site. Five years later, the lesion became more apparent than at the first visit (Fig. 2b). Since the yellowish-white lesion in this disease was once considered an inflammatory disease of the choroid, Hong et al. named it unifocal helicoid choroiditis in 1997 [9], and Shields et al. solitary idiopathic choroiditis in 2002 [10]. However, recent EDI-OCT findings prompted Fung et al. to rename these lesions to FSN, reporting that these lesions originate from the sclera and not the choroid [1]. In both cases of this report, the cooler LSFG color showed a focal reduction in blood flow. It is noteworthy that the LSFG findings were strictly localized in the lesion. Conversely, in inflammatory diseases such as punctate inner choroidopathy, whose primary condition is choroiditis, LSFG shows reductions in blood flow beyond the visible area of involvement on clinical exam [7], whereas in FSN, reduction in blood flow on LSFG is noted only in the area of involvement on clinical exam. The localized blood flow reduction in LSFG is a finding supporting the pathophysiology of FSN, a primary scleral elevation, and the resultant decrease in choroidal blood flow due to mechanical compression of the choroid.

          Related collections

          Most cited references10

          • Record: found
          • Abstract: found
          • Article: not found

          Macular choroidal blood flow velocity decreases with regression of acute central serous chorioretinopathy.

          To quantitatively evaluate the time course of macular choroidal blood flow velocity in acute central serous chorioretinopathy (CSC). This retrospective observational case series included 21 eyes of 20 patients (17 men, 3 women; mean age, 53.0 years) with treatment-naïve acute CSC. Laser speckle flowgraphy was performed to calculate macular mean blur rate (MBR), an indicator of relative blood flow velocity at the first visit, 3 and 6 months thereafter. Changes in average MBR values were compared with visual improvement at 6 months. Subretinal fluid completely resolved in all eyes within 6 months, while best-corrected visual acuity (BCVA) significantly improved at 6 months compared to the initial BCVA. During the follow-up period, the average MBR significantly decreased to 92.8% and 82.3% at 3 and 6 months, respectively, against baseline (100%). Importantly, there was a negative correlation between the BCVA recovery and the MBR decrease, showing the possible association of MBR increase with poor visual prognosis. Multiple regression analysis demonstrated no significant correlation between MBR and ocular perfusion pressure. These results indicate that macular choroidal blood flow velocity decreases concurrently with regression of CSC, suggesting a validity of choroidal blood flow elevation in the pathogenesis of acute CSC.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Pulse Waveform Changes in Macular Choroidal Hemodynamics With Regression of Acute Central Serous Chorioretinopathy.

            To quantitatively evaluate the pulse waveform changes in macular choroidal blood flow by using laser speckle flowgraphy (LSFG) with regression of acute central serous chorioretinopathy (CSC).
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Increased macular choroidal blood flow velocity and decreased choroidal thickness with regression of punctate inner choroidopathy

              Background Changes in choroidal circulation hemodynamics during the course of punctate inner choroidopathy (PIC) remain unknown. The aim of this study was to quantitatively evaluate changes in choroidal blood flow velocity by using laser speckle flowgraphy (LSFG) in patients with PIC. Case presentation This PIC patient was initially treated with systemic corticosteroids for 4 months. LSFG measurements were taken 10 consecutive times before treatment and at 1, 3, 12, 20 and 23 months after the initiation of therapy. The mean blur rate (MBR), a quantitative index of relative blood flow velocity, was calculated using LSFG in three regions: Circles 1, 2 and 3 were set at the fovea, a lesion site, and an area of normal-appearing retina, respectively. The PIC lesions scarred after treatment along with improvements in visual function and outer retinal morphology. When the changing rate of macular flow over the 12-month follow-up period was compared with the MBR before treatment (100%), an increase of 16–37%, 24–49% and 15–18% was detected in Circles 1, 2 and 3, respectively. At the time of PIC recurrence after 20 months, the MBR decreased temporarily but subsequently increased after retreatment with systemic corticosteroids. This trend was accompanied by a decrease in choroidal thickness at the lesion site after retreatment. Conclusions Macular choroidal blood flow velocity increased and choroidal thickness decreased concurrently with regression of PIC. The present findings suggest that inflammation-related impairments in choroidal circulation may relate to the pathogenesis of PIC, extending over a wider area in the posterior pole than the PIC lesions per se.
                Bookmark

                Author and article information

                Contributors
                s.michiyuki@med.hokudai.ac.jp
                Journal
                Graefes Arch Clin Exp Ophthalmol
                Graefes Arch Clin Exp Ophthalmol
                Graefe's Archive for Clinical and Experimental Ophthalmology
                Springer Berlin Heidelberg (Berlin/Heidelberg )
                0721-832X
                1435-702X
                8 September 2021
                8 September 2021
                2022
                : 260
                : 2
                : 697-700
                Affiliations
                GRID grid.39158.36, ISNI 0000 0001 2173 7691, Department of Ophthalmology, Faculty of Medicine and Graduate School of Medicine, , Hokkaido University, ; N-15, W-7, Kita-ku, Sapporo, 060-8638 Japan
                Article
                5391
                10.1007/s00417-021-05391-x
                8786776
                34495368
                1da8a3a8-e486-4fb4-8555-3837075e333a
                © The Author(s) 2021

                Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 22 June 2021
                : 7 August 2021
                : 13 August 2021
                Categories
                Letter to the Editor
                Custom metadata
                © Springer-Verlag GmbH Germany, part of Springer Nature 2022

                Ophthalmology & Optometry
                Ophthalmology & Optometry

                Comments

                Comment on this article